Selling a med spa involves preparation, confidential buyer outreach, offer negotiation, diligence, closing and a planned transition. This guide explains what to do at each stage and which decisions need legal, financial or clinical input. For the advisory service overview, see the confidential med spa sale process.
The Med Spa Sale Timeline
Plan around completion milestones rather than a promised number of weeks. Readiness, buyer financing, healthcare structure, provider continuity and third-party consents determine the schedule.
| Phase | Ready to advance when |
|---|---|
| Valuation and preparation | Financials, earnings adjustments, ownership structure and material risks can be explained and supported. |
| Confidential outreach | Qualified buyers have received appropriately staged information and can present credible proposals. |
| LOI and diligence | Economics, exclusivity and review rights are understood; financial, operational and legal issues are investigated. |
| Closing and transition | Definitive terms, required consents, funding and the operating handoff are ready. |
Step 1: Determine What Your Med Spa Is Worth
The process starts with a confidential valuation discussion. The goal is to understand what the med spa may be worth, what could affect buyer confidence, and whether the business is ready for a buyer process.
You will be asked to share:
- Three years of financial statements (P&L and balance sheet)
- Trailing twelve months revenue and adjusted EBITDA estimate
- A breakdown of revenue by service line
- Membership and recurring revenue data
- Lease, equipment, and medical director information
- Current corporate structure (MSO/PC, single entity, etc.)
The advisor reviews the financials on a normalized basis, pressure-tests add-backs, reviews treatment mix and transferability, and discusses a realistic valuation range. For valuation detail, see med spa valuation.
Common mistake at this stage: Sharing the optimistic version of the numbers instead of the supportable version. Buyers will test the financials anyway. Owners who present clean, realistic numbers early get more useful guidance.
Step 2: Prepare the Business for Sale
If the seller decides to move forward, preparation starts before buyer outreach. Buyers will review more than top-line revenue, so the work should cover financials, service-line performance, provider continuity, leases, equipment, staff, and compliance-sensitive structure.
Once engaged, the preparation work begins:
Financial rebuild. Your trailing financials are rebuilt on a buyer-ready basis. Owner compensation normalized. One-time items separated. Recurring versus one-time revenue split. Service mix margin breakdown. The output is the version of the P&L that a buyer or quality-of-earnings firm may test during diligence.
Confidential information memorandum (CIM). A buyer-facing account of the business, financials, team, growth opportunities and material risks. Its length should fit the practice, with every financial claim supported by the data room.
Anonymous teaser. A concise overview with identifying details withheld or generalized. Review combinations of geography, treatment mix and financial facts that might allow a buyer to infer the clinic’s identity.
Qualified buyer list assembly. The advisor builds a focused buyer list based on fit, capacity, track record, geography, service mix, and likely interest. The goal is not maximum exposure. It is selective qualified buyer outreach when appropriate.
Data room build. A secure online folder containing the documents a buyer will eventually review: financials, tax returns, leases, equipment lists, employment agreements, MSO/PC documentation where relevant, vendor contracts, marketing data, patient retention metrics, and provider information. Building it before market launch — instead of scrambling during diligence — is one of the biggest accelerants of a clean closing.
Common mistake at this stage: Underinvesting in preparation. A buyer can lose confidence quickly if financials, provider continuity, medical director arrangements, leases, or equipment obligations are unclear.
Step 3: Protect Confidentiality
Screen buyers and use an appropriate nondisclosure agreement before releasing identifying or sensitive information. Stage access, control site visits and coordinate provider, staff and third-party communications. No process guarantees secrecy, and an NDA does not authorize disclosure of protected patient information. See the staged-disclosure guide.
Step 4: Identify, Qualify, and Approach Buyers
Management calls. A 60–90 minute conversation between the seller and a buyer’s deal team. The buyer asks about strategy, the team, growth, the operating model, provider continuity, and any concerns raised by the materials.
Buyer qualification and IOI review. Buyers who want to advance may submit a non-binding indication of interest: a price range, structure, key terms, conditions, and timeline. Sellers should compare fit, credibility, confidentiality risk, and expected diligence burden, not just headline price.
Selective next-round review. Advancing buyers may receive deeper data room access, additional management interaction, and sometimes a site visit. Access should be staged so sensitive information is released only as buyer seriousness increases.
Step 5: Evaluate IOIs and Negotiate an LOI
Letter of intent (LOI) deadline. Shortlisted buyers submit LOIs with specific price, structure, terms, and exclusivity periods. The seller should compare the economics and obligations before choosing a path.
LOI selection. Selection is not always the highest headline number. A slightly lower price with cleaner terms, more cash at close, less earnout risk, smaller escrow, or a better post-close role may produce a better total economic outcome.
Common mistake at this stage: Picking the highest headline number without understanding the structure. A $5M LOI with $3M cash at close, $1M escrow held for two years, and $1M earnout contingent on performance is not the same as a $4.5M LOI with $4.2M cash at close. Sellers should compare the real economics before signing exclusivity.
IOI, LOI, Purchase Agreement, and Closing
Indication of Interest (IOI): A preliminary, generally non-binding expression of interest that may outline a valuation range, proposed structure, and key assumptions.
Letter of Intent (LOI): A more developed proposal stating the principal deal terms and establishing the framework for diligence and definitive documentation. Most economic terms remain non-binding.
Purchase agreement: The definitive contract setting the transaction terms, representations, warranties, covenants, indemnification provisions, and closing conditions.
Closing: The point at which required documents are executed, closing conditions are satisfied, consideration is delivered as agreed, and ownership transfers.
Step 6: Complete Buyer Due Diligence
After an LOI, the selected buyer investigates the business under the agreed access and exclusivity terms. Keep operations stable while advisers manage requests and track unresolved issues.
- Financial review: reconcile revenue, payroll, adjusted earnings, add-backs, prepaid treatment obligations and working capital. A quality-of-earnings review may be required.
- Legal and healthcare review: examine ownership, professional-entity arrangements, licensing, supervision, provider contracts, privacy, insurance and transaction-specific requirements with qualified counsel.
- Operational review: confirm device condition and financing, leases, software, staffing, vendor contracts and transferability.
Record findings, proposed remedies and their effect on price or terms. Use the med spa due-diligence checklist to organize evidence. Diligence informs the definitive agreement; it is not itself closing.
Step 7: Negotiate the Purchase Agreement and Close
Transaction counsel turns the agreed economics and diligence findings into definitive documents. Review representations, indemnities, escrow, working-capital definitions, debt treatment, earnout mechanics and closing conditions before signing.
Where the deal includes a working-capital adjustment, define the included accounts, target, calculation date and dispute process. Agree how equipment obligations and prepaid treatments are handled without double counting.
Close only when the required signatures, funding, consents, lien releases and operating arrangements are in place. The signed documents determine when ownership transfers and how consideration is delivered.
Step 8: Fulfill Post-Close Responsibilities
A closing does not necessarily end the seller’s obligations. The seller may have a defined handoff, employment or consulting role, continued clinical responsibilities, rollover ownership, an earnout, indemnities or restrictive covenants. Negotiate duration, compensation, authority, reporting, termination and release provisions for the actual role—there is no standard transition period for every med spa.
Coordinate lawful patient-record handling, provider continuity, systems access and stakeholder communications. Track later purchase-price adjustments, escrow releases and other surviving obligations with your advisers.
Frequently Asked Questions
How do I know whether my med spa is ready to sell?
Look for reliable financial records, supported earnings adjustments, organized healthcare documentation, stable provider relationships and a workable owner-transition plan. A readiness review can identify gaps before buyer outreach.
Should I get a valuation before approaching buyers?
A valuation baseline helps compare price and structure and identify preparation needs. It is an informed assessment, not a guaranteed transaction price.
Can I sell my med spa confidentially?
Anonymous outreach, buyer screening, NDAs, staged access and coordinated communications reduce unnecessary disclosure. They cannot guarantee that employees, patients or competitors will not learn about the process.
When should I involve an attorney?
Involve appropriate transaction and healthcare counsel early enough to review ownership, confidentiality, regulatory and contract issues before commitments are made. Have counsel review the LOI before signing; some provisions can be binding even when the purchase price is not.
How long will the sale take?
Timing depends on readiness, buyer fit, financing, diligence findings, required consents and definitive negotiations. Build a milestone schedule with your advisers and revise it as issues emerge; no fixed duration applies to every sale.
What if another offer arrives during exclusivity?
Ask counsel to review the exclusivity and notice provisions before engaging the new bidder or sharing information. An attractive offer does not override existing contractual obligations.
What happens if diligence does not lead to closing?
Identify whether the issue can be resolved and what the signed documents require about termination, expenses, confidentiality and exclusivity. Other buyers may remain options, but a renewed process and revised terms may be necessary.
Related Resources
Related reading: